SynthesisCardiovascular diabetology2017

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials.

Marit de Jong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.